Blue Horseshoe Stocks: CVS Update & More

CVS Health Corp. CVS - Recap

Included in yesterday morning’s premarket report, was an post earnings options idea for CVS. We were looking at the CVS Weekly $55.50-57 Calls following the company’s beat on Q2 earnings accompanied by raised guidance, and solid growth bolstered by the Aetna acquisition. The stock was also at a multiple-bottom area of the chart.

With the added help of an intraday market surge our targets enjoyed solid moves on the day.

$55.50 Calls – Range: 1.25-2.80 – Max Gain: 269%
$56 Calls – Range: .85-2.37 – Max Gain: 370%
$56.50 Calls – Range: .70-1.91  – Max Gain: 329%
$57 Calls – Range: .46-1.51 – Max Gain: 417%

We’ll look to roll up slightly and monitor the CVS Weekly $57.50-58 Calls for the remainder of the week.
_____

 More Fresh Ideas:
DISH Network Corp. DISH 09/13 $34-36 Calls
Advanced Micro Devices, Inc. AMD 08/16 $30.50-31.50 Calls
Uber, Inc. UBER Weekly $41-42.50 Calls 


Extended Watchist: 
MRO, AVLR, ET, DERM, TRGP, RLGY,

Blue Horseshoe Stocks: More Bottom-Plays

Seres Therapeutics, Inc. MCRB 

It was a pretty slow start to the week yesterday with the markets gapping up early, but falling into decline throughout the session. That didn’t stop the one fresh idea we did have in our morning report from posting a respectable performance on the day.

We referred to MCRB as a ‘prime bottom play’ and while it didn’t exactly explode out of the gate, what we did see was certainly a step in the right direction. From a low of 2.63, the stock ran a modest but solid 16% to a high of 3.06. More importantly, it preserved its momentum by holding the three-dollar mark into the close. A good first day by any stretch of the imagination.

We’ll continue to monitor our longer term options idea that we included, the MCRB 07/19 $2.50 Calls which stand to do well in coming weeks if the stock can continue to maintain the current trend. Yesterday’s session was the fourth consecutive day that the stock has recorded higher lows, and we’ll want to see more of that moving forward.


Verastem Inc. VSTM 

Speaking of bottom plays, we’ve got another one to add to our radars this morning in VSTM. This stock has lost a ton of value over the past year, and recently began to show signs of a rebound. We like it for its technical setup and volatility potential. We will remain interested in tracking VSTM for as long as it can maintain support at 1.72 or better.

VSTM is considered by some to be a speculative buyout play as well. Just this week the company has reported positive early stage data on Copiktra, the company’s leukemia treatment under development. Definitely an interesting story to follow.

____

Celestica Inc. CLS

Perhaps even more attractive as a bottom play than the above mentioned stock, we’ve got CLS, which just began to show signs of life after recording a new annual low at the beginning of this month.

If the stock can manage to break its 50DMA at 7.09, there’s a real chance that it could produce significant gains, filling the gap to the topside on the chart. Interesting to naote about CLS as well, is that the company’s EPS has grown by nearly 90% over the past year. When taking that into consideration, its current valuation doesn’t make a whole lot of sense.


Extended Watchlist:
CBAY, DERM, SAVA, NERV, NDRA, PHUN, VIVE

Blue Horseshoe Stocks: SAGD Review & More

South American Gold Corp. SAGD
(soon to be Sativa Growth International)

On the morning of last Thursday the 21st, we signaled our interest in tracking SAGD, and at the time the stock was trading as low as .0135. In the week of trading which has followed, the stock has made a very nice move.

Yesterday, SAGD hit a new high of .0364 which represents a one-week upswing of 170% and continues our recent impressive trend of identifying not only hot options plays, but scoring big with stocks as well.

We should also mention that the company announced its plans to change its name and official focus to reflect the work it has been doing to move toward the cannabis space.(>>Read PR) It’s one of our favorite OTC market sectors, and we’ll be tracking SAGD as part of it moving forward.


Accenture plc. ACN – Recap

Speaking of success in options ideas, our fresh play from yesterday morning’s premarket report yielded fantastic single-session results. We designated the ACN Weekly $157.50-162.50 Calls as our go-to options play for the day and all three of the contracts contained in our highlighted range were big-time winners on the day.

$157.50 Calls – Range: 2.36-7.41 – Max Gain: 214%
$160 Calls – Range: 1.24-5.60 – Max Gain: 352%
$162.50 Calls – Range: .50-3.10 – Max Gain: 520%
_______

Fresh Options Ideas:
Nike Inc. – NKE Weekly $77-79 Calls
SPDRA S&P 500 ETF – SPY Weekly $270-272 Calls


Extended Watchlist:
IQ, BAC, VRTX, ACAD, DERM, PIR(bottom-watch)